Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126106181 | 12610618 | 1 | I | 20160523 | 20160801 | 20160801 | EXP | US-INSYS THERAPEUTICS, INC-INS201605-000247 | INSYS | FAREED A,BUCHANAN-CUMMINGS A,CRAMPTON K,GRANT A,DREXLER K. REVERSAL OF OVERDOSE ON FENTANYL BEING ILLICITLY SOLD AS HEROIN WITH NALOXONE NASAL SPRAY: A CASE REPORT. AM J ADDICT 2015;24:388-90. | 0.00 | M | Y | 0.00000 | 20160801 | MD | GE | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126106181 | 12610618 | 1 | PS | FENTANYL. | FENTANYL | 1 | U | 202788 | |||||||||||
| 126106181 | 12610618 | 2 | SS | HEROIN | DIACETYLMORPHINE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126106181 | 12610618 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126106181 | 12610618 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126106181 | 12610618 | Accidental overdose | |
| 126106181 | 12610618 | Cyanosis | |
| 126106181 | 12610618 | Loss of consciousness | |
| 126106181 | 12610618 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |